低剂量电离辐射与高血压之间的关联:中国的一项队列研究
Beining Wu1, Lin Song1, Lan Lin1
1Division of Epidemiology and Medical Statistics, School of Public Health, Nantong University, Se Yuan Road, No 9, Nantong, 226019, Jiangsu, China.
概括
长期暴露于低剂量的电离辐射 (<20mSv) 会增加石油工人的高血压风险. 较高的累积辐射剂量与高血压发生率和血压水平的增加相关.
科学领域:
- 职业健康 职业健康 职业健康
- 环境健康 环境健康
- 心血管流行病学心血管流行病学
背景情况:
- 高剂量的电离辐射与高血压有关,但低剂量 (<20 mSv) 的影响尚不清楚.
- 石油工人面临着可能长期暴露于电离辐射的危险.
- 了解低剂量辐射的影响对于职业安全至关重要.
研究的目的:
- 评估石油工人暴露于低剂量的电离辐射 (<20mSv) 的高血压风险.
- 为了确定累积辐射剂量与高血压发病率之间的关系.
- 评估辐射暴露与血压水平之间的关联.
主要方法:
- 一项对新疆卡拉马伊地区2658名石油和石化工业工人的队列研究 (2013年7月 - 2019年12月).
- 对X射线和马射线的评估暴露在0-110.84mSv的剂量范围内.
- 使用"中国高血压预防和治疗指南"确定高血压病例;进行后勤回归分析.
主要成果:
- 长期低剂量电离辐射暴露是高血压的重要危险因素 (RR=2.09).
- 随着累积暴露剂量的增加,高血压的风险增加,特别是在5.17mSv以上.
- 缩和透缩血压与增加的累积辐射剂量 (P<0.05) 有正相关性.
结论:
- 低剂量的电离辐射 (<20mSv) 与石油工人的高血压发病率增加有关.
- 累积辐射暴露剂量是影响高血压风险和血压的关键因素.
- 这些发现强调了在职业环境中监测和控制低剂量辐射暴露的必要性.
相关概念视频
02:59Biological Effects of Radiation
15.4K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
15.4K
01:18Hypertension and Regulation of Blood Pressure
2.0K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K
01:12Hazard Ratio
99
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
99